$INCY
INCYTE CORP

2021 Q4 Form 10-Q Financial Statement

#000155837021014131 Filed on November 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $862.9M $813.0M $620.6M
YoY Change 9.29% 30.99% 12.52%
Cost Of Revenue $38.57M $39.87M $34.32M
YoY Change 24.43% 16.16% 14.25%
Gross Profit $824.3M $773.1M $586.3M
YoY Change 8.67% 31.86% 12.42%
Gross Profit Margin 95.53% 95.1% 94.47%
Selling, General & Admin $226.2M $190.7M $120.8M
YoY Change 35.45% 57.88% 17.72%
% of Gross Profit 27.44% 24.67% 20.6%
Research & Development $472.8M $334.9M $438.1M
YoY Change 16.49% -23.55% 55.72%
% of Gross Profit 57.36% 43.32% 74.72%
Depreciation & Amortization $14.86M $14.69M $12.90M
YoY Change 12.56% 13.88% -7.19%
% of Gross Profit 1.8% 1.9% 2.2%
Operating Expenses $704.3M $525.6M $558.9M
YoY Change 21.79% -5.95% 45.57%
Operating Profit $119.9M $235.4M $5.326M
YoY Change -33.44% 4320.02% -96.03%
Interest Expense $3.570M $439.0K $544.0K
YoY Change -8.46% -19.3% -8.88%
% of Operating Profit 2.98% 0.19% 10.21%
Other Income/Expense, Net $5.716M $1.948M $4.917M
YoY Change -60.38% -58.89%
Pretax Income $120.0M $209.5M -$3.508M
YoY Change -28.6% -6071.18% -102.37%
Income Tax -$443.8M $27.70M $11.70M
% Of Pretax Income -369.8% 13.22%
Net Earnings $563.9M $181.7M -$15.20M
YoY Change 276.28% -1295.42% -111.85%
Net Earnings / Revenue 65.35% 22.35% -2.45%
Basic Earnings Per Share $0.82 -$0.07
Diluted Earnings Per Share $2.540M $0.82 -$0.07
COMMON SHARES
Basic Shares Outstanding 220.9M 220.8M 218.8M
Diluted Shares Outstanding 222.2M 218.8M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.348B $2.284B $1.735B
YoY Change 30.36% 31.66% -12.66%
Cash & Equivalents $2.057B $1.999B $1.498B
Short-Term Investments $290.8M $285.1M $237.0M
Other Short-Term Assets $126.3M $101.7M $51.40M
YoY Change 110.11% 97.92% 3.01%
Inventory $27.90M $21.30M $17.00M
Prepaid Expenses
Receivables $616.3M $516.5M $356.1M
Other Receivables $0.00 $200.0K $100.0K
Total Short-Term Assets $3.119B $2.924B $2.159B
YoY Change 32.15% 35.4% -6.91%
LONG-TERM ASSETS
Property, Plant & Equipment $723.9M $686.7M $498.3M
YoY Change 29.36% 37.8% 43.51%
Goodwill $155.6M $155.6M $155.6M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $221.3M $192.1M $222.8M
YoY Change -0.47% -13.78% 88.97%
Other Assets $37.30M $24.79M $53.11M
YoY Change -5.33% -53.33% 37.49%
Total Long-Term Assets $1.815B $1.275B $1.148B
YoY Change 51.09% 11.07% 28.24%
TOTAL ASSETS
Total Short-Term Assets $3.119B $2.924B $2.159B
Total Long-Term Assets $1.815B $1.275B $1.148B
Total Assets $4.933B $4.199B $3.307B
YoY Change 38.54% 26.95% 2.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $172.1M $114.5M $122.5M
YoY Change 74.26% -6.53% 28.45%
Accrued Expenses $533.6M $481.9M $334.3M
YoY Change 41.01% 44.14% 33.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.635M $2.400M $13.90M
YoY Change 14.57% -82.73% 1637.5%
Total Short-Term Liabilities $854.3M $742.7M $606.2M
YoY Change 35.35% 22.52% 31.3%
LONG-TERM LIABILITIES
Long-Term Debt $31.63M $31.38M $32.80M
YoY Change -2.97% -4.34% -34.14%
Other Long-Term Liabilities $70.41M $62.31M $44.60M
YoY Change 20.82% 39.71% 31.59%
Total Long-Term Liabilities $70.41M $62.31M $44.60M
YoY Change 20.82% 39.71% 31.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $854.3M $742.7M $606.2M
Total Long-Term Liabilities $70.41M $62.31M $44.60M
Total Liabilities $1.163B $1.050B $916.6M
YoY Change 22.5% 14.57% 15.69%
SHAREHOLDERS EQUITY
Retained Earnings -$777.9M -$1.342B -$1.876B
YoY Change -54.94% -28.49% 21.7%
Common Stock $4.567B $4.509B $4.277B
YoY Change 4.92% 5.43% 7.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.770B $3.149B $2.391B
YoY Change
Total Liabilities & Shareholders Equity $4.933B $4.199B $3.307B
YoY Change 38.54% 26.95% 2.88%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $563.9M $181.7M -$15.20M
YoY Change 276.28% -1295.42% -111.85%
Depreciation, Depletion And Amortization $14.86M $14.69M $12.90M
YoY Change 12.56% 13.88% -7.19%
Cash From Operating Activities $115.4M $255.1M $182.1M
YoY Change 7.5% 40.09% -32.66%
INVESTING ACTIVITIES
Capital Expenditures -$34.46M -$32.15M -$52.80M
YoY Change -33.08% -39.1% -412.43%
Acquisitions
YoY Change
Other Investing Activities -$31.58M -$601.0K $38.40M
YoY Change -38.43% -101.57% -934.78%
Cash From Investing Activities -$66.05M -$32.75M -$14.50M
YoY Change -35.69% 125.89% -217.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.005M -19.34M 900.0K
YoY Change -24.33% -2249.22% -68.97%
NET CHANGE
Cash From Operating Activities 115.4M 255.1M 182.1M
Cash From Investing Activities -66.05M -32.75M -14.50M
Cash From Financing Activities 9.005M -19.34M 900.0K
Net Change In Cash 58.31M 203.0M 168.5M
YoY Change 253.39% 20.48% -41.0%
FREE CASH FLOW
Cash From Operating Activities $115.4M $255.1M $182.1M
Capital Expenditures -$34.46M -$32.15M -$52.80M
Free Cash Flow $149.8M $287.3M $234.9M
YoY Change -5.66% 22.29% -7.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityNoncurrent
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
CY2021Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
INCYTE CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000879169
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
220885119
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
219489329
CY2021Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2021Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityCurrent
CY2021Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2021Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12400
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3136539
dei Entity Address Address Line1
EntityAddressAddressLine1
1801 Augustine Cut-Off
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19803
dei City Area Code
CityAreaCode
302
dei Local Phone Number
LocalPhoneNumber
498-6700
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
dei Trading Symbol
TradingSymbol
INCY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
220890618
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1999021000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1513008000
CY2021Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
285135000
CY2020Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
288199000
CY2021Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
285054000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
288369000
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
516689000
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
481994000
CY2021Q3 us-gaap Inventory Net
InventoryNet
21303000
CY2020Q4 us-gaap Inventory Net
InventoryNet
16425000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
101730000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
60098000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2923797000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2359894000
CY2021Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1682000
CY2020Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1757000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
192096000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
222301000
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
30885000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
19548000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
686718000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
559625000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27133000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
28451000
CY2021Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
156139000
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
172291000
CY2021Q3 us-gaap Goodwill
Goodwill
155593000
CY2020Q4 us-gaap Goodwill
Goodwill
155593000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24788000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41458000
CY2021Q3 us-gaap Assets
Assets
4198831000
CY2020Q4 us-gaap Assets
Assets
3560918000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
114509000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
98767000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105705000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
113340000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
481879000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
378404000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2400000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2284000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
38219000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
38400000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
742712000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
631195000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
213781000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
227600000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31376000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32573000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
62305000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
58282000
CY2021Q3 us-gaap Liabilities
Liabilities
1050174000
CY2020Q4 us-gaap Liabilities
Liabilities
949650000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
220885119
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
219489329
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
221000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
219000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4508807000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4352864000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18646000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15360000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1341725000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1726455000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3148657000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2611268000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4198831000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3560918000
CY2021Q3 us-gaap Revenues
Revenues
812987000
CY2020Q3 us-gaap Revenues
Revenues
620643000
us-gaap Revenues
Revenues
2123414000
us-gaap Revenues
Revenues
1877193000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
39869000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
34322000
us-gaap Cost Of Revenue
CostOfRevenue
107117000
us-gaap Cost Of Revenue
CostOfRevenue
95005000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
334945000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
438109000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
985352000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1809997000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
190704000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120788000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
513358000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
349934000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2910000
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
7109000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13068000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19790000
CY2021Q3 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
9149000
CY2020Q3 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
14989000
incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
29476000
incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
30372000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
577577000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
615317000
us-gaap Costs And Expenses
CostsAndExpenses
1648371000
us-gaap Costs And Expenses
CostsAndExpenses
2305098000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
235410000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5326000
us-gaap Operating Income Loss
OperatingIncomeLoss
475043000
us-gaap Operating Income Loss
OperatingIncomeLoss
-427905000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1948000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4917000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4931000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18396000
CY2021Q3 us-gaap Interest Expense
InterestExpense
439000
CY2020Q3 us-gaap Interest Expense
InterestExpense
544000
us-gaap Interest Expense
InterestExpense
1156000
us-gaap Interest Expense
InterestExpense
1746000
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-27450000
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-13207000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-28394000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
10935000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
209469000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3508000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
450424000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-400320000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27730000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11695000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65694000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45227000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
181739000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15203000
us-gaap Net Income Loss
NetIncomeLoss
384730000
us-gaap Net Income Loss
NetIncomeLoss
-445547000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220845000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218784000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220243000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217684000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3286000
CY2021Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1466
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222248000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218784000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222113000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217684000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
181739000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15203000
us-gaap Net Income Loss
NetIncomeLoss
384730000
us-gaap Net Income Loss
NetIncomeLoss
-445547000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-629000
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2532000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4061000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5085000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-86000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-77000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-251000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
CY2021Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-342000
CY2020Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-220000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1026000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-661000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-373000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2675000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5794000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
181366000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12528000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
381444000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-439753000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2611268000
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
389512
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20028000
CY2021Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1357
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
108000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47903000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4998000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
53535000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2727844000
CY2021Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
390001
CY2021Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
153082
CY2021Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
11016000
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1288
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
109000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45351000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2085000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
149456000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2935861000
CY2021Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
459084
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-11992000
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
108000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43314000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-373000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
181739000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3148657000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2598406000
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
772538
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14619000
CY2020Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1957
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
145000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42758000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2435000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-720642000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1937721000
CY2020Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
936688
CY2020Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
175615
CY2020Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
69194000
CY2020Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1403
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
139000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
162000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46406000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
684000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
290298000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2344604000
CY2020Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
698032
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7783000
CY2020Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1434
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
131000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6873000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43970000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2675000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15203000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2390833000
us-gaap Profit Loss
ProfitLoss
384730000
us-gaap Profit Loss
ProfitLoss
-445547000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42986000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38641000
us-gaap Share Based Compensation
ShareBasedCompensation
134784000
us-gaap Share Based Compensation
ShareBasedCompensation
132616000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
178000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5268000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8698000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-28394000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
10935000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13068000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19790000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34695000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55656000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24784000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11384000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16215000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9204000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15742000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
38865000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
85037000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
62196000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
634137000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-231920000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
8662000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
95468000
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
10473000
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
17250000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
146543000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
135946000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
228170000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
418698000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
231250000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
466591000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-141652000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-166271000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
19052000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
91596000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1788000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
619000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
20093000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
31140000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2829000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59837000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3718000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5085000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
485938000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-333269000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1514765000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1833707000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000703000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1500438000
us-gaap Interest Paid Net
InterestPaidNet
119000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45872000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
56787000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6992000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
23892000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12836000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9068000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13020000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
455000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
2160000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates.</i>  The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Concentrations of Credit Risk.</i>  Cash, cash equivalents, marketable securities, and trade receivables are financial instruments which potentially subject us to concentrations of credit risk. The estimated fair value of financial instruments </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">approximates the carrying value based on available market information. By policy, we invest our excess available funds primarily in U.S. government debt securities which are securities issued or guaranteed by the U.S. government and money market funds that meet certain guidelines, which limits exposure to potential credit losses. Our receivables mainly relate to our product sales and collaborative agreements with pharmaceutical companies. We have not experienced any significant credit losses on cash, cash equivalents, marketable securities, or trade receivables to date and do not require collateral on receivables.</p>
incy Inventory Finished Goods Useful Life Maximum
InventoryFinishedGoodsUsefulLifeMaximum
P36M
CY2021Q3 incy Variable Interest Entities Number
VariableInterestEntitiesNumber
0
incy Percentage Of Medi Care Part D Insurance Coverage Gap Required To Be Funded By Manufacturers
PercentageOfMediCarePartDInsuranceCoverageGapRequiredToBeFundedByManufacturers
0.70
incy Medicare Part D Insurance Coverage Gap Increase In Eligible Patient Spending Percentage
MedicarePartDInsuranceCoverageGapIncreaseInEligiblePatientSpendingPercentage
0.30
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
13700000
us-gaap Advertising Expense
AdvertisingExpense
32000000.0
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
6400000
us-gaap Advertising Expense
AdvertisingExpense
16500000
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
812987000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
620643000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2123414000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1877193000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
35988000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21242000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14925000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13456000
CY2021Q3 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
52188000
CY2020Q4 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
35973000
CY2021Q3 us-gaap Inventory Net
InventoryNet
21303000
CY2020Q4 us-gaap Inventory Net
InventoryNet
16425000
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
30885000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
19548000
CY2021Q3 us-gaap Inventory Net
InventoryNet
21300000
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
30900000
CY2021Q3 incy Inventory Recorded As Research And Development Expense
InventoryRecordedAsResearchAndDevelopmentExpense
72100000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
854512000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
703999000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167794000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
144374000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
686718000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
559625000
us-gaap Lessee Operating Lease Existence Of Residual Value Guarantee
LesseeOperatingLeaseExistenceOfResidualValueGuarantee
false
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9849000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12674000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2400000
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.041
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
400000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000000.0
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2900000
us-gaap Operating Lease Cost
OperatingLeaseCost
9000000.0
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.088
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3500000
us-gaap Operating Lease Cost
OperatingLeaseCost
10700000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2000000.0
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2284000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14951000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14188000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31376000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32573000
CY2021Q3 incy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
58576000
CY2020Q4 incy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
61719000
us-gaap Operating Lease Payments
OperatingLeasePayments
11400000
us-gaap Operating Lease Payments
OperatingLeasePayments
8700000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1800000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
600000
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P13Y7M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1900000
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
300000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
900000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5385000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
21536000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21536000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
21536000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21536000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
64610000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134800000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
132600000
CY2021Q3 incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
600000
incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
1800000
CY2020Q3 incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
200000
incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes valuation model
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3284583
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
87.42
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3634147
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
87.07
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5515182
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
9500000
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesGranted
6162583
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCanceled
1567041
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10419640
incy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Annualized Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedAnnualizedForfeitureRate
0.05
CY2021Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
142446000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
106011000
CY2021Q3 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
125290000
CY2020Q4 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
115897000
CY2021Q3 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
105749000
CY2020Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
73204000
CY2021Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
23892000
CY2020Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
22807000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9849000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12674000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74653000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47811000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
481879000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
378404000
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4400000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
12800000
CY2020Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
10100000
CY2021Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1975000
CY2020Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1523000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
5927000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
4457000
CY2021Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
23000
CY2020Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
49000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
68000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
142000
CY2021Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
15000
CY2020Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
32000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
45000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
93000
CY2021Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
CY2020Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
162000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
161000
CY2021Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-288000
CY2020Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-166000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-864000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-500000
CY2021Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2325000
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1760000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
6976000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
5167000
CY2021Q3 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
5300000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65700000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11700000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45200000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
7300000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
5400000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
181739000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-445547000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220845000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218784000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222248000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218784000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222113000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217684000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.73
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220243000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217684000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1403000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1870000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15203000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
384730000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-445547000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220845000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218784000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220243000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217684000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
181739000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15203000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
384730000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11841440
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15678728
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9917824
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15678728

Files In Submission

Name View Source Status
0001558370-21-014131-index-headers.html Edgar Link pending
0001558370-21-014131-index.html Edgar Link pending
0001558370-21-014131.txt Edgar Link pending
0001558370-21-014131-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
incy-20210930.xsd Edgar Link pending
incy-20210930x10q.htm Edgar Link pending
incy-20210930x10q_htm.xml Edgar Link completed
incy-20210930xex10d1.htm Edgar Link pending
incy-20210930xex10d1001.jpg Edgar Link pending
incy-20210930xex10d1002.jpg Edgar Link pending
incy-20210930xex31d1.htm Edgar Link pending
incy-20210930xex31d2.htm Edgar Link pending
incy-20210930xex32d1.htm Edgar Link pending
incy-20210930xex32d2.htm Edgar Link pending
incy-20210930_cal.xml Edgar Link unprocessable
incy-20210930_def.xml Edgar Link unprocessable
incy-20210930_lab.xml Edgar Link unprocessable
incy-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending